Skip to main content
Equibles
HSIC logo

HSIC · Henry Schein Inc · Metrics

Track HSIC — free

Use HSIC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HSIC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$84.51 -0.45 (-0.53%) At close · Oct 26
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$9.47B
Shares
111.45M
Volume · Oct 26 937.98K Avg daily vol (3M) 1.2M

HSIC metrics

108 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$84.51
Market cap
$9.47B

Price action

20 metrics
Price change (1W)
+0.6%
Price change (30D)
-1.7%
Price change (3M)
-0.1%
Price change (6M)
+9.5%
Price change (YTD)
+11.8%
Price change (1Y)
+32.4%
Trailing year
Price change (5Y)
+12.2%
52-week high
$90.86
52-week low
$62.32
Change from 52-week high
-7.0%
Change from 52-week low
+35.6%
Annualized volatility
25.6%
Annualized volatility (3M)
18.5%
Beta
0.5
RSI (14D)
45.7
Price vs SMA 50
-2.7%
Price vs SMA 200
+4.5%
Avg volume (3M)
1.20M
Relative volume
0.8
Average dollar volume
$103.76M

Company

3 metrics
Sector
Healthcare
Industry
Medical Distribution
Shares outstanding
111.45M

Valuation

12 metrics
P / E (TTM)
24.6
Trailing earnings · reciprocal yield 4.1%
PEG ratio
1.4
EV / revenue
0.9×
reciprocal yield 115.8%
EV / EBITDA
11.7×
reciprocal yield 8.6%
EV / EBIT
17.3×
reciprocal yield 5.8%
P / sales
0.7×
reciprocal yield 143.7%
P / book
3.0
reciprocal yield 33.3%
FCF yield
6.0%
TTM · current market cap
Buyback yield
7.7%
P / FCF
16.6
reciprocal yield 6.0%
P / operating cash flow
13.5
reciprocal yield 7.4%
Earnings yield
4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
23.5×
reciprocal yield 4.3%
P / E historical average (5Y)
21.7×
reciprocal yield 4.6%
EV / revenue historical average (3Y)
0.9×
reciprocal yield 116.6%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 115.4%
EV / EBIT historical average (3Y)
17.7×
reciprocal yield 5.7%
EV / EBIT historical average (5Y)
16.5×
reciprocal yield 6.0%
EV / EBITDA historical average (3Y)
12.7×
reciprocal yield 7.9%
EV / EBITDA historical average (5Y)
12.2×
reciprocal yield 8.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
7.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
31.3%
Operating margin
5.0%
Trailing 12 months
Net margin
3.0%
Gross profit (TTM)
$4.26B
Operating profit (TTM)
$680.00M
Net income (TTM)
$403.00M
Trailing 12 months
Diluted EPS (TTM)
$3.43
FCF margin
4.2%
Effective tax rate
23.8%

Per share

11 metrics
Revenue per diluted share (TTM)
$115.88
Gross profit per diluted share (TTM)
$36.30
Operating profit per diluted share (TTM)
$5.80
EBITDA per diluted share (TTM)
$8.58
Net income per diluted share (TTM)
$3.43
Operating cash flow per diluted share (TTM)
$5.94
Free cash flow per diluted share (TTM)
$4.82
Capital expenditures per diluted share (TTM)
$1.11
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.33
Book value per share
$28.03

Growth

11 metrics
Revenue growth YoY
+6.7%
Year over year
Net income growth YoY
+9.3%
Revenue (TTM)
$13.60B
Trailing 12 months
EPS growth YoY
+17.1%
Shares change YoY
-6.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+1.4%
Revenue CAGR (5Y)
+5.4%
EPS CAGR (3Y)
-5.8%
EPS CAGR (5Y)
+3.0%
FCF CAGR (3Y)
+4.2%
FCF CAGR (5Y)
+0.8%

Quality

14 metrics
Return on equity
12.8%
Return on assets
3.5%
Debt / equity
0.8
Current ratio
1.3
EBITDA (TTM)
$1.01B
Free cash flow (TTM)
$569.00M
Quick ratio
0.7
Interest coverage
4.3
Net debt / EBITDA
2.3
Return on invested capital
9.5%
Trailing 12 months
Net cash
−$2.28B
Latest balance sheet
Cash & equivalents
$157.00M
Total assets
$11.38B
Total debt
$2.44B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$700.00M
Capital expenditures (TTM)
$131.00M
R&D (TTM)
—
SG&A (TTM)
$3.21B
Stock compensation (TTM)
$39.00M
R&D / revenue
—
Stock compensation / revenue
0.3%

Ownership (13F)

9 metrics
13F filers
570
13F filer change QoQ
+2
Institutional ownership
111.1%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.7%
Holder tenure
15.7
Price vs estimated holder cost
+13.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
20.4%

Short interest

3 metrics
Short interest
8.1%
Latest settlement · 7.0 days to cover
Days to cover
7.0d
Short-squeeze score
77 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1000228 CUSIP 806407102 13F (30d) 135 filings 129 filers Visit website Investor relations